Arjun Jj Desai
CIK: 0001982985
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 19, 2026LGVN
Longeveron Inc.
Award(A)Direct36K shares- - Aug 13, 2026CLNN
Clene Inc.
Award(A)Directstock option
3.7K shares- - May 21, 2026CLNN
Clene Inc.
Award(A)Directstock option
1.5K shares- - May 21, 2026CLNN
Clene Inc.
Award(A)Directstock option
2.2K shares- - Feb 19, 2026CLNN
Clene Inc.
Award(A)Directstock option
3.2K shares- - Nov 13, 2025CLNN
Clene Inc.
Award(A)Directstock option
2.2K shares- - Aug 14, 2025CLNN
Clene Inc.
Award(A)Directstock option
4.3K shares- - Jun 12, 2025TLSI
TriSalus Life Sciences, Inc.
Award(A)DirectDirector Stock Option (right to buy)
15K shares- - May 22, 2025CLNN
Clene Inc.
Award(A)DirectStock Options (Right to buy)
6K shares- - May 22, 2025CLNN
Clene Inc.
Award(A)DirectStock Options (Right to buy)
1.5K shares- - Feb 27, 2025CLNN
Clene Inc.
Award(A)DirectStock Options (Right to buy)
3.3K shares- - Dec 10, 2024TLSI
TriSalus Life Sciences, Inc.
Sale(S)Direct30K shares at avg. $3.69$111K - Dec 6, 2024CLNN
Clene Inc.
Award(A)DirectStock Options (Right to buy)
3.3K shares- - Oct 2, 2024CLNN
Clene Inc.
Award(A)DirectStock Options (Right to buy)
2.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 19, 2026 |  LGVN Longeveron Inc. | Award(A) | 36,000 | - | $0 | Direct |
| Aug 13, 2026 |  CLNN Clene Inc. | Award(A) stock option | 3,674 | - | - | Direct |
| May 21, 2026 | CLNN Clene Inc. | Award(A) stock option | 1,500 | - | - | Direct |
| May 21, 2026 | CLNN Clene Inc. | Award(A) stock option | 2,158 | - | - | Direct |
| Feb 19, 2026 | CLNN Clene Inc. | Award(A) stock option | 3,168 | - | - | Direct |
| Nov 13, 2025 | CLNN Clene Inc. | Award(A) stock option | 2,177 | - | - | Direct |
| Aug 14, 2025 | CLNN Clene Inc. | Award(A) stock option | 4,278 | - | - | Direct |
| Jun 12, 2025 |  TLSI TriSalus Life Sciences, Inc. | Award(A) Director Stock Option (right to buy) | 15,000 | - | - | Direct |
| May 22, 2025 | CLNN Clene Inc. | Award(A) Stock Options (Right to buy) | 6,021 | - | - | Direct |
| May 22, 2025 | CLNN Clene Inc. | Award(A) Stock Options (Right to buy) | 1,500 | - | - | Direct |
| Feb 27, 2025 | CLNN Clene Inc. | Award(A) Stock Options (Right to buy) | 3,319 | - | - | Direct |
| Dec 10, 2024 | TLSI TriSalus Life Sciences, Inc. | Sale(S) | 30,000 | $3.69 | $110,700 | Direct |
| Dec 6, 2024 | CLNN Clene Inc. | Award(A) Stock Options (Right to buy) | 3,280 | - | - | Direct |
| Oct 2, 2024 | CLNN Clene Inc. | Award(A) Stock Options (Right to buy) | 2,943 | - | - | Direct |
1-14 of 14 transactions
About Desai Arjun JJ
Desai Arjun JJ (SEC CIK 0001982985) files insider reports with the SEC as Director of Longeveron Inc. (LGVN), Director of Clene Inc. (CLNN) and Director of TriSalus Life Sciences, Inc. (TLSI).
Signal8 holds 13 ownership filings by Desai Arjun JJ (1 Form 3, 12 Form 4), filed between Oct 3, 2024 and Aug 21, 2026. Those filings report 14 transactions, from Oct 2, 2024 to Aug 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Desai Arjun JJ's filings is in SALT LAKE CITY, UT.
Recent filings by Desai Arjun JJ
- Aug 19, 2026: Grant or award of LGVN shares (Form 4, code A).
- Aug 13, 2026: Grant or award of CLNN derivative securities (Form 4, code A).
- May 21, 2026: Grants or awards of CLNN derivative securities (2 lines, Form 4, code A).
- Feb 19, 2026: Grant or award of CLNN derivative securities (Form 4, code A).
- Nov 13, 2025: Grant or award of CLNN derivative securities (Form 4, code A).
Other insiders filing for Longeveron Inc. (LGVN)
- Jhaveri Nirav S., Chief Financial Officer
- Willard Stephen H, Chief Executive Officer
- Agafonova Nataliya, Chief Medical Officer
- Lehr Paul T, General Counsel, Secretary
- Blass Devin, CTO & SVP of CMC
- Hajjar Roger Joseph, Director